Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Consolidation”

769 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 769 results

Testing effectiveness (Phase 2)UnknownNCT02502968
What this trial is testing

BL-8040 Addition to Consolidation Therapy in AML Patients

Who this might be right for
Acute Myeloid Leukemia
Dr. Petra Tschanter 194
Testing effectiveness (Phase 2)Looking for participantsNCT06376526
What this trial is testing

IMMUNOPLANT for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Dickran Kazandjian, MD 28
Testing effectiveness (Phase 2)Ended earlyNCT03381118
What this trial is testing

Haploidentical Lymphocytes With Nivolumab/Ara-C as Consolidation in Elderly AML Patients

Who this might be right for
Acute Myeloid Leukemia
St. Petersburg State Pavlov Medical University 16
Testing effectiveness (Phase 2)Study completedNCT00497315
What this trial is testing

Evaluation of Pemetrexed Combined With Cisplatin and Radiotherapy for Unresectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
University Hospital, Antwerp 30
Large-scale testing (Phase 3)Study completedNCT00216125
What this trial is testing

Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Nasser Hanna, M.D. 243
Early research (Phase 1)Study completedNCT00101153
What this trial is testing

Tipifarnib, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
University Health Network, Toronto 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT05801939
What this trial is testing

Cevostamab Following CAR T Cell Therapy for RRMM

Who this might be right for
Relapsed/Refractory Multiple Myeloma
University of Pennsylvania 30
Early research (Phase 1)Study completedNCT01798004
What this trial is testing

Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

Who this might be right for
GanglioneuroblastomaStage 1 NeuroblastomaStage 2 Neuroblastoma+5 more
Children's Oncology Group 150
Large-scale testing (Phase 3)Study completedNCT00416208
What this trial is testing

Consolidation Therapy With Bortezomib in Elderly Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen-Cilag G.m.b.H 154
Not applicableStudy completedNCT06149390
What this trial is testing

ASCT Versus Chemotherapy as First-Line Consolidation Therapy inT-Cell Lymphoma

Who this might be right for
T-cell Lymphoma Adults
Huazhong University of Science and Technology 347
Testing effectiveness (Phase 2)Ended earlyNCT00271323
What this trial is testing

Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients

Who this might be right for
Non-Small-Cell Lung Carcinoma
Sanofi 14
Post-approval studies (Phase 4)Ended earlyNCT03657212
What this trial is testing

Enhancing Memory Consolidation in Older Adults

Who this might be right for
Aging
University of California, Irvine 10
Not applicableNo Longer AvailableNCT02624570
What this trial is testing

Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy

Who this might be right for
Acute Myeloid Leukemia (AML) WithFLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD)
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Active Not RecruitingNCT03710772
What this trial is testing

Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
M.D. Anderson Cancer Center 51
Large-scale testing (Phase 3)Study completedNCT01208766
What this trial is testing

Study to Compare VMP With HDM Followed by VRD Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Stichting Hemato-Oncologie voor Volwassenen Nederland 1,503
Testing effectiveness (Phase 2)UnknownNCT00349505
What this trial is testing

Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma

Who this might be right for
Epithelial Ovarian CarcinomaFigo Stage IIIC
Gustave Roussy, Cancer Campus, Grand Paris 67
Early research (Phase 1)Study completedNCT01390337
What this trial is testing

Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)

Who this might be right for
Leukemia, Myeloid, Acute
Daiichi Sankyo 19
Not applicableEnded earlyNCT03648775
What this trial is testing

Evaluation of the Clinical Efficacy of Y-STRUT® Medical Device Implanted for Contralateral Percutaneous Internal Fixation of Proximal Femur, in Patient With a Low Energy Per Trochanteric Fracture on the First Side

Who this might be right for
Fracture of HipOsteoporosis
Hyprevention 10
Early research (Phase 1)UnknownNCT04687657
What this trial is testing

Umbilical Cord Blood Transfusion in Consolidation Therapy of Elderly Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia, Myelomonocytic, Acute
First Affiliated Hospital Xi'an Jiaotong University 20
Not applicableEnded earlyNCT04818021
What this trial is testing

Contribution of the Somatosensory System to Speech Perceptual Processing

Who this might be right for
SpeechConsolidation
Yale University 160
Load More Results